Surgical procedure in which the STOMACH is transected high on the body. The resulting small proximal gastric pouch is joined to any parts of the SMALL INTESTINE by an end-to-side SURGICAL ANASTOMOSIS, depending on the amounts of intestinal surface being bypasses. This procedure is used frequently in the treatment of MORBID OBESITY by limiting the size of functional STOMACH, food intake, and food absorption.
The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. In the BODY MASS INDEX, morbid obesity is defined as having a BMI greater than 40.0 kg/m2.
A Y-shaped surgical anastomosis of any part of the digestive system which includes the small intestine as the eventual drainage site.
Surgical procedures involving the STOMACH and sometimes the lower ESOPHAGUS to correct anatomical defects, or to treat MORBID OBESITY by reducing the size of the stomach. There are several subtypes of bariatric gastroplasty, such as vertical banded gastroplasty, silicone ring vertical gastroplasty, and horizontal banded gastroplasty.
Decrease in existing BODY WEIGHT.
Surgical procedures aimed at affecting metabolism and producing major WEIGHT REDUCTION in patients with MORBID OBESITY.
A procedure in which a laparoscope (LAPAROSCOPES) is inserted through a small incision near the navel to examine the abdominal and pelvic organs in the PERITONEAL CAVITY. If appropriate, biopsy or surgery can be performed during laparoscopy.
A surgical procedure which diverts pancreatobiliary secretions via the duodenum and the jejunum into the colon, the remaining small intestine being anastomosed to the stomach after antrectomy. The procedure produces less diarrhea than does jejunoileal bypass.
Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.
A peptide of 36 or 37 amino acids that is derived from PROGLUCAGON and mainly produced by the INTESTINAL L CELLS. GLP-1(1-37 or 1-36) is further N-terminally truncated resulting in GLP-1(7-37) or GLP-1-(7-36) which can be amidated. These GLP-1 peptides are known to enhance glucose-dependent INSULIN release, suppress GLUCAGON release and gastric emptying, lower BLOOD GLUCOSE, and reduce food intake.
A status with BODY WEIGHT that is grossly above the acceptable or desirable weight, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
Surgical formation of an opening through the ABDOMINAL WALL into the JEJUNUM, usually for enteral hyperalimentation.
The period following a surgical operation.
Fastening devices composed of steel-tantalum alloys used to close operative wounds, especially of the skin, which minimizes infection by not introducing a foreign body that would connect external and internal regions of the body. (From Segen, Current Med Talk, 1995)
A 36-amino acid peptide produced by the L cells of the distal small intestine and colon. Peptide YY inhibits gastric and pancreatic secretion.
A condition that is characterized by chronic fatty DIARRHEA, a result of abnormal DIGESTION and/or INTESTINAL ABSORPTION of FATS.
Abnormal passage communicating with the STOMACH.
The middle portion of the SMALL INTESTINE, between DUODENUM and ILEUM. It represents about 2/5 of the remaining portion of the small intestine below duodenum.
Excretion of an excessive amount of OXALATES in the urine.
An organ of digestion situated in the left upper quadrant of the abdomen between the termination of the ESOPHAGUS and the beginning of the DUODENUM.
Peptides which stimulate INSULIN release from the PANCREATIC BETA CELLS following oral nutrient ingestion, or postprandially.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
An indicator of body density as determined by the relationship of BODY WEIGHT to BODY HEIGHT. BMI=weight (kg)/height squared (m2). BMI correlates with body fat (ADIPOSE TISSUE). Their relationship varies with age and gender. For adults, BMI falls into these categories: below 18.5 (underweight); 18.5-24.9 (normal); 25.0-29.9 (overweight); 30.0 and above (obese). (National Center for Health Statistics, Centers for Disease Control and Prevention)
Creation of an artificial external opening into the stomach for nutritional support or gastrointestinal compression.
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
The period of care beginning when the patient is removed from surgery and aimed at meeting the patient's psychological and physical needs directly after surgery. (From Dictionary of Health Services Management, 2d ed)
A condition due to a deficiency of one or more essential vitamins. (Dorland, 27th ed)
A gastrointestinal peptide hormone of about 43-amino acids. It is found to be a potent stimulator of INSULIN secretion and a relatively poor inhibitor of GASTRIC ACID secretion.
The selection of one food over another.
Coronary artery bypass surgery on a beating HEART without a CARDIOPULMONARY BYPASS (diverting the flow of blood from the heart and lungs through an oxygenator).
A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
Physiologic mechanisms which regulate or control the appetite and food intake.
Protrusion of tissue, structure, or part of an organ through the bone, muscular tissue, or the membrane by which it is normally contained. Hernia may involve tissues such as the ABDOMINAL WALL or the respiratory DIAPHRAGM. Hernias may be internal, external, congenital, or acquired.
A repeat operation for the same condition in the same patient due to disease progression or recurrence, or as followup to failed previous surgery.
The time frame after a meal or FOOD INTAKE.
A technique of closing incisions and wounds, or of joining and connecting tissues, in which staples are used as sutures.
A double-layered fold of peritoneum that attaches the STOMACH to other organs in the ABDOMINAL CAVITY.
Elements of limited time intervals, contributing to particular results or situations.
Pathological development in the JEJUNUM region of the SMALL INTESTINE.
The period before a surgical operation.
Glucose in blood.
Surgical union or shunt between ducts, tubes or vessels. It may be end-to-end, end-to-side, side-to-end, or side-to-side.
The condition of an anatomical structure's being constricted beyond normal dimensions.
A 28-amino acid, acylated, orexigenic peptide that is a ligand for GROWTH HORMONE SECRETAGOGUE RECEPTORS. Ghrelin is widely expressed but primarily in the stomach in the adults. Ghrelin acts centrally to stimulate growth hormone secretion and food intake, and peripherally to regulate energy homeostasis. Its large precursor protein, known as appetite-regulating hormone or motilin-related peptide, contains ghrelin and obestatin.
General term for a group of MALNUTRITION syndromes caused by failure of normal INTESTINAL ABSORPTION of nutrients.
An inherited autosomal recessive syndrome characterized by the disorganized formation of new islets in the PANCREAS and CONGENITAL HYPERINSULINISM. It is due to focal hyperplasia of pancreatic ISLET CELLS budding off from the ductal structures and forming new islets of Langerhans. Mutations in the islet cells involve the potassium channel gene KCNJ11 or the ATP-binding cassette transporter gene ABCC8, both on CHROMOSOME 11.
Breakdown of the connection and subsequent leakage of effluent (fluids, secretions, air) from a SURGICAL ANASTOMOSIS of the digestive, respiratory, genitourinary, and cardiovascular systems. Most common leakages are from the breakdown of suture lines in gastrointestinal or bowel anastomosis.
Sweet food products combining cane or beet sugars with other carbohydrates and chocolate, milk, eggs, and various flavorings. In the United States, candy refers to both sugar- and cocoa-based confections and is differentiated from sweetened baked goods; elsewhere the terms sugar confectionary, chocolate confectionary, and flour confectionary (meaning goods such as cakes and pastries) are used.
Formation of stones in the KIDNEY.
Behavioral response associated with the achieving of gratification.
A procedure consisting of the SURGICAL ANASTOMOSIS of the proximal part of the JEJUNUM to the distal portion of the ILEUM, so as to bypass the nutrient-absorptive segment of the SMALL INTESTINE. Due to the severe malnutrition and life-threatening metabolic complications, this method is no longer used to treat MORBID OBESITY.
HORMONES secreted by the gastrointestinal mucosa that affect the timing or the quality of secretion of digestive enzymes, and regulate the motor activity of the digestive system organs.
Excision of the whole (total gastrectomy) or part (subtotal gastrectomy, partial gastrectomy, gastric resection) of the stomach. (Dorland, 28th ed)
A protrusion of abdominal structures through the retaining ABDOMINAL WALL. It involves two parts: an opening in the abdominal wall, and a hernia sac consisting of PERITONEUM and abdominal contents. Abdominal hernias include groin hernia (HERNIA, FEMORAL; HERNIA, INGUINAL) and VENTRAL HERNIA.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
Reduction in caloric intake without reduction in adequate nutrition. In experimental animals, caloric restriction has been shown to extend lifespan and enhance other physiological variables.
A variety of surgical reconstructive procedures devised to restore gastrointestinal continuity, The two major classes of reconstruction are the Billroth I (gastroduodenostomy) and Billroth II (gastrojejunostomy) procedures.
The degree to which BLOOD VESSELS are not blocked or obstructed.
A colorless crystalline or white powdery organic, tricarboxylic acid occurring in plants, especially citrus fruits, and used as a flavoring agent, as an antioxidant in foods, and as a sequestrating agent. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
The vein which drains the foot and leg.
Sensation of enjoyment or gratification.
The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
The period of confinement of a patient to a hospital or other health facility.
I'm sorry for any confusion, but "Utah" is a proper noun and refers to a state in the United States, it does not have a medical definition. If you have any medical questions or need information on specific medical conditions or terms, I would be happy to help!
Gastrointestinal symptoms resulting from an absent or nonfunctioning pylorus.

Gastric surgery for pseudotumor cerebri associated with severe obesity. (1/591)

OBJECTIVE: To study the efficacy of gastric surgery-induced weight loss for the treatment of pseudotumor cerebri (PTC). SUMMARY BACKGROUND DATA: Pseudotumor cerebri (also called idiopathic intracranial hypertension), a known complication of severe obesity, is associated with severe headaches, pulsatile tinnitus, elevated cerebrospinal fluid (CSF) pressures, and normal brain imaging. The authors have found in previous clinical and animal studies that PTC in obese persons is probably secondary to a chronic increase in intraabdominal pressure leading to increased intrathoracic pressure. CSF-peritoneal shunts have a high failure rate, probably because they involve shunting from a high-pressure system to another high-pressure zone. In an earlier study of gastric bypass surgery in eight patients, CSF pressure decreased from 353+/-35 to 168+/-12 mm H2O at 34+/-8 months after surgery, with resolution of headaches in all. METHODS: Twenty-four severely obese women underwent bariatric surgery--23 gastric bypasses and one laparoscopic adjustable gastric banding--62+/-52 months ago for the control of severe obesity associated with PTC. CSF pressures were 324+/-83 mm H2O. Additional PTC central nervous system and cranial nerve problems included peripheral visual field loss, trigeminal neuralgia, recurrent Bell's palsy, and pulsatile tinnitus. Spontaneous CSF rhinorrhea occurred in one patient, and hemiplegia with homonymous hemianopsia developed as a complication of ventriculoperitoneal shunt placement in another. There were two occluded lumboperitoneal shunts and another functional but ineffective lumboperitoneal shunt. Additional obesity comorbidity in these patients included degenerative joint disease, gastroesophageal reflux disease, hypertension, urinary stress incontinence, sleep apnea, obesity hypoventilation, and type II diabetes mellitus. RESULTS: At 1 year after bariatric surgery, 19 patients lost an average of 45+/-12 kg, which was 71+/-18% of their excess weight. Their body mass index and percentage of ideal body weight had fallen to 30+/-5 kg/m2 and 133+/-22%, respectively. In four patients, less than 1 year had elapsed since surgery. Five patients were lost to follow-up. Surgically induced weight loss was associated with resolution of headache and pulsatile tinnitus in all but one patient within 4 months of the procedure. The cranial nerve dysfunctions resolved in all patients. The patient with CSF rhinorrhea had resolution within 4 weeks of gastric bypass. Of the 19 patients not lost to follow-up, 2 regained weight, with recurrence of headache and pulsatile tinnitus. Additional resolved associated comorbidities were 6/14 degenerative joint disease, 9/10 gastroesophageal reflux disorder, 2/6 hypertension, and all with sleep apnea, hypoventilation, type II diabetes mellitus, and urinary incontinence. CONCLUSIONS: Bariatric surgery is the long-term procedure of choice for severely obese patients with PTC and is shown to have a much higher rate of success than CSF-peritoneal shunting reported in the literature, as well as providing resolution of additional obesity comorbidity. Increased intraabdominal pressure associated with central obesity is the probable etiology of PTC, a condition that should no longer be considered idiopathic.  (+info)

Treatment for morbid obesity. (2/591)

There is no single unifying theory to explain the aetiology of obesity but several environmental factors, such as decreased physical activity and increased fat intake may contribute to its development in genetically predisposed individuals. Dietary and pharmacological treatments of morbid obesity have been proven to be unsuccessful. Modern surgical treatments have been shown to be effective in achieving significant weight loss with consequent reduction in morbidity. Despite the fact that surgical treatment of morbid obesity is the only therapeutic form that has stood the test of time, it still remains a crisis-driven form of therapy in the UK. It is probable that a better understanding of the aetiology and physiology of obesity may lead to the development of an effective pharmacological treatment of obesity in the future. However, until then, surgical treatment of morbid obesity should be considered as an effective and efficient way of treatment in selected cases.  (+info)

Laparoscopic Roux-en-Y gastric bypass for morbid obesity. (3/591)

Surgery is currently the only effective treatment for morbid obesity. The two most commonly accepted operations are the Roux-en-Y gastric bypass and vertical banded gastroplasty. Although multiple authors have reported on a laparoscopic approach to gastric banding, the Roux-en-Y gastric bypass is a complex operation to be replicated using laparoscopic techniques. In this article, we describe our technique of the Roux-en-Y gastric bypass using a laparoscopic approach in four cases.  (+info)

Late outcome of isolated gastric bypass. (4/591)

OBJECTIVE: To complete a long-term (>5 years) follow-up of patients undergoing isolated gastric bypass for severe obesity. SUMMARY BACKGROUND DATA: Previous experience as well as randomized trials suggested that the ideal operation for obesity should rely on manipulation of satiety rather than the production of malabsorption. Such an operation should incorporate a small gastric pouch of less than 30 mL placed in a dependent position on the lesser curvature of the stomach, not dependent on staples, and separated from the remaining stomach with a retrocolic, retrogastric Roux-en-Y gastrojejunostomy without external support. METHODS: The authors established an obesity clinic where patients were seen six times during the first year and semiannually thereafter. Emphasis was placed on defining success in terms of approximation to normal body-mass index. RESULTS: Of 274 patients, 243 (89%) were followed up for 5.5 +/- 1.5 years. Before surgery, the patients were obese (n = 13), morbidly obese (n = 134), or super-obese (n = 96). The obese and morbidly obese group achieved an excellent result, and the super-obese a good result. Individual results showed considerable variation from the mean. CONCLUSIONS: This study of isolated gastric bypass with a 5.5-year follow-up rate of 88.6% revealed a success rate of 93% in obese or morbidly obese patients and 57% in super-obese patients. Isolated gastric bypass compares favorably with biliopancreatic diversion in terms of weight loss, maximum weight loss, weight regain, current body-mass index, and percentage of patients with a body-mass index less than 35 kg/m2.  (+info)

Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. (5/591)

OBJECTIVE: To evaluate the short-term outcomes for laparoscopic Roux-en-Y gastric bypass in 275 patients with a follow-up of 1 to 31 months. SUMMARY BACKGROUND DATA: The Roux-en-Y gastric bypass is a highly successful approach to morbid obesity but results in significant perioperative complications. A laparoscopic approach has significant potential to reduce perioperative complications and recovery time. METHODS: Consecutive patients (n = 275) who met NIH criteria for bariatric surgery were offered laparoscopic Roux-en-Y gastric bypass between July 1997 and March 2000. A 15-mL gastric pouch and a 75-cm Roux limb (150 cm for superobese) was created using five or six trocar incisions. RESULTS: The conversion rate to open gastric bypass was 1%. The start of an oral diet began a mean of 1.58 days after surgery, with a median hospital stay of 2 days and return to work at 21 days. The incidence of early major and minor complications was 3.3% and 27%, respectively. One death occurred related to a pulmonary embolus (0.4%). The hernia rate was 0.7%, and wound infections requiring outpatient drainage only were uncommon (5%). Excess weight loss at 24 and 30 months was 83% and 77%, respectively. In patients with more than 1 year of follow-up, most of the comorbidities were improved or resolved, and 95% reported significant improvement in quality of life. CONCLUSION: Laparoscopic Roux-en-Y gastric bypass is effective in achieving weight loss and in improving comorbidities and quality of life while reducing recovery time and perioperative complications.  (+info)

High failure rate after laparoscopic adjustable silicone gastric banding for treatment of morbid obesity. (6/591)

OBJECTIVE: To report the results from one of the eight original U.S. centers performing laparoscopic adjustable silicone gastric banding (LASGB), a new minimally invasive surgical technique for treatment of morbid obesity. SUMMARY BACKGROUND DATA: Laparoscopic adjustable silicone gastric banding is under evaluation by the Food & Drug Administration in the United States in an initial cohort of 300 patients. METHODS: Of 37 patients undergoing laparoscopic placement of the LASGB device, successful placement occurred in 36 from March 1996 to May 1998. Patients have been followed up for up to 4 years. RESULTS: Five patients (14%) have been lost to follow-up for more than 2 years but at last available follow-up (3-18 months after surgery) had achieved only 18% (range 5-38%) excess weight loss. African American patients had poor weight loss after LASGB compared with whites. The LASGB devices were removed in 15 (41%) patients 10 days to 42 months after surgery. Four patients underwent simple removal; 11 were converted to gastric bypass. The most common reason for removal was inadequate weight loss in the presence of a functioning band. The primary reasons for removal in others were infection, leakage from the inflatable silicone ring causing inadequate weight loss, or band slippage. The patients with band slippage had concomitant poor weight loss. Bands were removed in two others as a result of symptoms related to esophageal dilatation. In 18 of 25 patients (71%) who underwent preoperative and long-term postoperative contrast evaluation, a significantly increased esophageal diameter developed; of these, 13 (72%) had prominent dysphagia, vomiting, or reflux symptoms. Of the remaining 21 patients with bands, 8 currently desire removal and conversion to gastric bypass for inadequate weight loss. Six of the remaining patients have persistent morbid obesity at least 2 years after surgery but refuse to undergo further surgery or claim to be satisfied with the results. Overall, only four patients achieved a body-mass index of less than 35 and/or at least a 50% reduction in excess weight. Thus, the overall need for band removal and conversion to GBP in this series will ultimately exceed 50%. CONCLUSIONS: The authors did not find LASGB to be an effective procedure for the surgical treatment of morbid obesity. Complications after LASGB include esophageal dilatation, band leakage, infection, erosion, and slippage. Inadequate weight loss is common, particularly in African American patients. More study is required to determine the long-term efficacy of the LASGB  (+info)

Alternative operative techniques in laparoscopic Roux-en-Y gastric bypass for morbid obesity. (7/591)

The only effective treatment for patients with morbid obesity is surgery. Laparoscopic bariatric surgery has become quite popular in attempts to decrease the morbidity associated with laparotomy. In this article, we describe the technical details of laparoscopic Roux-en-Y gastric bypass with three different techniques for creating the 15-cc gastric pouch. These techniques avoid upper endoscopy for the transoral introduction of the 21-mm circular stapler anvil down to the gastric pouch.  (+info)

Risks and benefits of gastric bypass in morbidly obese patients with severe venous stasis disease. (8/591)

OBJECTIVE: To determine the risks and benefits of gastric bypass-induced weight loss on severe venous stasis disease in morbid obesity. SUMMARY BACKGROUND DATA: Severe obesity is associated with a risk of lower extremity venous stasis disease, pretibial ulceration, cellulitis, and bronze edema. METHODS: The GBP database was queried for venous stasis disease including pretibial venous stasis ulcers, bronze edema, and cellulitis. RESULTS: Of 1,976 patients undergoing GBP, 64 (45% female) met the criteria. Mean age was 44 +/- 10 years. Thirty-seven patients had pretibial venous stasis ulcers, 4 had bronze edema, 23 had both, and 17 had recurrent cellulitis. All had 2 to 4+ pitting pretibial edema. Mean preoperative body mass index (BMI) was 61 +/- 12 kg/m(2) and weight was 179 +/- 39 kg (270 +/- 51% ideal body weight), significantly greater than in patients who underwent GBP without venous stasis disease. Two patients had a pulmonary embolus and four had Greenfield filters in the remote past. Additional comorbidities included obesity hypoventilation syndrome, sleep apnea syndrome, hypertension, gastroesophageal reflux, degenerative joint disease symptoms, type 2 diabetes mellitus, pseudotumor cerebri, and urinary incontinence. Comorbidities were significantly more frequent in the patients with venous stasis disease than for those without. At 3.9 +/- 4 years after surgery, patients lost 55 +/- 21 % of excess weight, 62 +/- 33 kg, reaching 40 +/- 9 kg/m(2) BMI or 176 +/- 41% ideal body weight. Venous stasis ulcers resolved in all but three patients. Complications included anastomotic leaks with peritonitis and death, fatal pulmonary embolism, fatal respiratory arrest, wound infections or seromas, staple line disruptions, marginal ulcerations treated with acid suppression, stomal stenoses treated with endoscopic dilatation, late small bowel obstructions, and incisional hernias. There were six other late deaths. CONCLUSIONS: Severe venous stasis disease was associated with a significantly greater weight, BMI, male sex, age, comorbidity, and surgical risk (pulmonary embolus, leak, death, incisional hernia) than in other patients who underwent GBP. Surgically induced weight loss corrected the venous stasis disease in almost all patients as well as their other obesity-related problems.  (+info)

Gastric bypass is a surgical procedure that involves creating a small pouch in the stomach and rerouting the small intestine to connect to this pouch, thereby bypassing the majority of the stomach and the first part of the small intestine (duodenum). This procedure is typically performed as a treatment for morbid obesity and related health conditions such as type 2 diabetes, sleep apnea, and high blood pressure.

The smaller stomach pouch restricts food intake, while the rerouting of the small intestine reduces the amount of calories and nutrients that are absorbed, leading to weight loss. Gastric bypass can also result in hormonal changes that help regulate appetite and metabolism, further contributing to weight loss and improved health outcomes.

There are different types of gastric bypass procedures, including Roux-en-Y gastric bypass and laparoscopic gastric bypass. The choice of procedure depends on various factors such as the patient's overall health, medical history, and personal preferences. Gastric bypass is generally considered a safe and effective treatment for morbid obesity, but like any surgical procedure, it carries risks and requires careful consideration and preparation.

Morbid obesity is a severe form of obesity, defined by a body mass index (BMI) of 40 or higher or a BMI of 35 or higher in the presence of at least one serious obesity-related health condition, such as diabetes, high blood pressure, or sleep apnea. It is called "morbid" because it significantly increases the risk of various life-threatening health problems and reduces life expectancy.

Morbid obesity is typically associated with significant excess body weight, often characterized by a large amount of abdominal fat, that can strain the body's organs and lead to serious medical complications, such as:

* Type 2 diabetes
* High blood pressure (hypertension)
* Heart disease
* Stroke
* Sleep apnea and other respiratory problems
* Nonalcoholic fatty liver disease (NAFLD)
* Osteoarthritis
* Certain types of cancer, such as breast, colon, and endometrial cancer

Morbid obesity can also have significant negative impacts on a person's quality of life, including mobility issues, difficulty with daily activities, and increased risk of mental health problems, such as depression and anxiety. Treatment for morbid obesity typically involves a combination of lifestyle changes, medication, and in some cases, surgery.

Roux-en-Y anastomosis is a type of surgical connection between two parts of the gastrointestinal tract, typically performed during gastric bypass surgery for weight loss. In this procedure, a small pouch is created from the upper stomach, and the remaining portion of the stomach is bypassed. The Roux limb, a segment of the small intestine, is then connected to both the pouch and the bypassed stomach, creating two separate channels for food and digestive juices to mix. This surgical technique helps to reduce the amount of food that can be consumed and absorbed, leading to weight loss.

Gastroplasty is a surgical procedure that involves reducing the size of the stomach to treat morbid obesity. It is also known as vertical banded gastroplasty or stomach stapling. In this procedure, a part of the stomach is permanently stapled vertically to create a small pouch at the top of the stomach. This restricts the amount of food that can be eaten at one time and causes a feeling of fullness with smaller amounts of food.

The goal of gastroplasty is to help patients lose weight by reducing their calorie intake, promoting weight loss, and improving overall health. However, it is important to note that gastroplasty requires significant lifestyle changes, including regular exercise and healthy eating habits, to maintain long-term weight loss success.

As with any surgical procedure, there are risks associated with gastroplasty, such as infection, bleeding, and complications related to anesthesia. It is important for patients to discuss these risks with their healthcare provider before deciding whether or not to undergo the procedure.

Weight loss is a reduction in body weight attributed to loss of fluid, fat, muscle, or bone mass. It can be intentional through dieting and exercise or unintentional due to illness or disease. Unintentional weight loss is often a cause for concern and should be evaluated by a healthcare professional to determine the underlying cause and develop an appropriate treatment plan. Rapid or significant weight loss can also have serious health consequences, so it's important to approach any weight loss plan in a healthy and sustainable way.

Bariatric surgery is a branch of medicine that involves the surgical alteration of the stomach, intestines, or both to induce weight loss in individuals with severe obesity. The primary goal of bariatric surgery is to reduce the size of the stomach, leading to decreased food intake and absorption, which ultimately results in significant weight loss.

There are several types of bariatric surgeries, including:

1. Roux-en-Y gastric bypass (RYGB): This procedure involves creating a small pouch at the top of the stomach and connecting it directly to the middle portion of the small intestine, bypassing the rest of the stomach and the upper part of the small intestine.
2. Sleeve gastrectomy: In this procedure, a large portion of the stomach is removed, leaving behind a narrow sleeve-shaped pouch that restricts food intake.
3. Adjustable gastric banding (AGB): This surgery involves placing an adjustable band around the upper part of the stomach to create a small pouch and limit food intake.
4. Biliopancreatic diversion with duodenal switch (BPD/DS): This is a more complex procedure that involves both restricting the size of the stomach and rerouting the small intestine to reduce nutrient absorption.

Bariatric surgery can lead to significant weight loss, improvement in obesity-related health conditions such as diabetes, high blood pressure, sleep apnea, and reduced risk of mortality. However, it is not without risks and complications, including infection, bleeding, nutrient deficiencies, and dumping syndrome. Therefore, careful consideration and evaluation by a multidisciplinary team are necessary before undergoing bariatric surgery.

Laparoscopy is a surgical procedure that involves the insertion of a laparoscope, which is a thin tube with a light and camera attached to it, through small incisions in the abdomen. This allows the surgeon to view the internal organs without making large incisions. It's commonly used to diagnose and treat various conditions such as endometriosis, ovarian cysts, infertility, and appendicitis. The advantages of laparoscopy over traditional open surgery include smaller incisions, less pain, shorter hospital stays, and quicker recovery times.

Biliopancreatic diversion is a surgical procedure for the treatment of morbid obesity. It involves creating a small pouch from the lower part of the stomach and connecting it directly to the last portion of the small intestine (ileum), bypassing the majority of the stomach and duodenum. This results in a significant reduction in food intake, as well as malabsorption of nutrients such as fats, proteins, and vitamins.

The procedure is designed to promote weight loss through restriction and malabsorption. The small pouch restricts the amount of food that can be consumed at one time, while the bypassed portion of the intestine reduces the absorption of calories from food. This results in a significant reduction in calorie intake, leading to weight loss.

However, due to the malabsorption of nutrients, patients who undergo biliopancreatic diversion are at risk for nutrient deficiencies and require lifelong supplementation with vitamins and minerals. The procedure also carries a higher risk of complications such as dumping syndrome, ulcers, and malnutrition compared to other weight loss surgeries.

It is important to note that biliopancreatic diversion should only be considered in patients who are severely obese (with a body mass index or BMI greater than 50) and have not been successful with non-surgical weight loss methods. The decision to undergo this procedure should be made in consultation with a team of healthcare professionals, including a bariatric surgeon, dietitian, and mental health professional.

Postoperative complications refer to any unfavorable condition or event that occurs during the recovery period after a surgical procedure. These complications can vary in severity and may include, but are not limited to:

1. Infection: This can occur at the site of the incision or inside the body, such as pneumonia or urinary tract infection.
2. Bleeding: Excessive bleeding (hemorrhage) can lead to a drop in blood pressure and may require further surgical intervention.
3. Blood clots: These can form in the deep veins of the legs (deep vein thrombosis) and can potentially travel to the lungs (pulmonary embolism).
4. Wound dehiscence: This is when the surgical wound opens up, which can lead to infection and further complications.
5. Pulmonary issues: These include atelectasis (collapsed lung), pneumonia, or respiratory failure.
6. Cardiovascular problems: These include abnormal heart rhythms (arrhythmias), heart attack, or stroke.
7. Renal failure: This can occur due to various reasons such as dehydration, blood loss, or the use of certain medications.
8. Pain management issues: Inadequate pain control can lead to increased stress, anxiety, and decreased mobility.
9. Nausea and vomiting: These can be caused by anesthesia, opioid pain medication, or other factors.
10. Delirium: This is a state of confusion and disorientation that can occur in the elderly or those with certain medical conditions.

Prompt identification and management of these complications are crucial to ensure the best possible outcome for the patient.

Glucagon-like peptide 1 (GLP-1) is a hormone that is secreted by the intestines in response to food intake. It plays a crucial role in regulating blood sugar levels through several mechanisms, including stimulation of insulin secretion from the pancreas, inhibition of glucagon release, slowing gastric emptying, and promoting satiety. GLP-1 is an important target for the treatment of type 2 diabetes due to its insulin-secretory and glucose-lowering effects. In addition, GLP-1 receptor agonists are used in the management of obesity due to their ability to promote weight loss by reducing appetite and increasing feelings of fullness.

Obesity is a complex disease characterized by an excess accumulation of body fat to the extent that it negatively impacts health. It's typically defined using Body Mass Index (BMI), a measure calculated from a person's weight and height. A BMI of 30 or higher is indicative of obesity. However, it's important to note that while BMI can be a useful tool for identifying obesity in populations, it does not directly measure body fat and may not accurately reflect health status in individuals. Other factors such as waist circumference, blood pressure, cholesterol levels, and blood sugar levels should also be considered when assessing health risks associated with weight.

A jejunostomy is a surgical procedure where an opening (stoma) is created in the lower part of the small intestine, called the jejunum. This stoma allows for the passage of nutrients and digestive enzymes from the small intestine into a tube or external pouch, bypassing the mouth, esophagus, stomach, and upper small intestine (duodenum).

Jejunostomy is typically performed to provide enteral nutrition support in patients who are unable to consume food or liquids by mouth due to various medical conditions such as dysphagia, gastroparesis, bowel obstruction, or after certain surgical procedures. The jejunostomy tube can be used for short-term or long-term nutritional support, depending on the patient's needs and underlying medical condition.

The postoperative period is the time following a surgical procedure during which the patient's response to the surgery and anesthesia is monitored, and any complications or adverse effects are managed. This period can vary in length depending on the type of surgery and the individual patient's needs, but it typically includes the immediate recovery phase in the post-anesthesia care unit (PACU) or recovery room, as well as any additional time spent in the hospital for monitoring and management of pain, wound healing, and other aspects of postoperative care.

The goals of postoperative care are to ensure the patient's safety and comfort, promote optimal healing and rehabilitation, and minimize the risk of complications such as infection, bleeding, or other postoperative issues. The specific interventions and treatments provided during this period will depend on a variety of factors, including the type and extent of surgery performed, the patient's overall health and medical history, and any individualized care plans developed in consultation with the patient and their healthcare team.

Surgical staplers are medical devices used in various surgical procedures to create secure and precise connections between tissues, vessels, or organs. They function by placing sterile, disposable staple cartridges into the device that contain rows of stainless steel staples. The stapler then applies pressure to deform the staples, forming a B-shaped staple line that holds the tissue together.

These devices are often used in place of traditional suturing methods due to their speed, accuracy, and ability to reduce surgical trauma. They can be employed in various types of surgeries, including gastrointestinal, thoracic, gynecologic, and orthopedic procedures.

Surgical staplers come in different shapes and sizes, with some designed for specific applications such as linear or circular stapling. Linear staplers are used to create straight lines of staples, while circular staplers form a ring-shaped connection, often used in anastomosis procedures (the joining of two hollow organs or vessels).

It is essential to follow proper techniques and indications when using surgical staplers, as improper usage can lead to complications such as bleeding, infection, leakage, or even tissue necrosis.

Peptide YY (PYY) is a small peptide hormone consisting of 36 amino acids, that is released by the L cells in the intestinal epithelium in response to feeding. It is a member of the neuropeptide Y (NPY) family and plays a crucial role in regulating appetite and energy balance.

After eating, PYY is released into the circulation and acts on specific receptors in the hypothalamus to inhibit food intake. This anorexigenic effect of PYY is mediated by its ability to decrease gastric emptying, reduce intestinal motility, and increase satiety.

PYY has also been shown to have effects on glucose homeostasis, insulin secretion, and inflammation, making it a potential therapeutic target for the treatment of obesity, diabetes, and other metabolic disorders.

Steatorrhea is a medical condition characterized by the excessive amount of fat in stools, which can make them appear greasy, frothy, and foul-smelling. This occurs due to poor absorption of dietary fats in the intestines, a process called malabsorption. The most common causes of steatorrhea include conditions that affect the pancreas, such as cystic fibrosis or chronic pancreatitis, celiac disease, and other gastrointestinal disorders. Symptoms associated with steatorrhea may include abdominal pain, bloating, diarrhea, weight loss, and vitamin deficiencies due to malabsorption of fat-soluble vitamins (A, D, E, K). The diagnosis typically involves testing stool samples for fat content and further investigations to determine the underlying cause. Treatment is focused on addressing the underlying condition and providing dietary modifications to manage symptoms.

A gastric fistula is an abnormal connection or passage between the stomach and another organ or the skin surface. This condition can occur as a result of complications from surgery, injury, infection, or certain diseases such as cancer. Symptoms may include persistent drainage from the site of the fistula, pain, malnutrition, and infection. Treatment typically involves surgical repair of the fistula and management of any underlying conditions.

The jejunum is the middle section of the small intestine, located between the duodenum and the ileum. It is responsible for the majority of nutrient absorption that occurs in the small intestine, particularly carbohydrates, proteins, and some fats. The jejunum is characterized by its smooth muscle structure, which allows it to contract and mix food with digestive enzymes and absorb nutrients through its extensive network of finger-like projections called villi.

The jejunum is also lined with microvilli, which further increase the surface area available for absorption. Additionally, the jejunum contains numerous lymphatic vessels called lacteals, which help to absorb fats and fat-soluble vitamins into the bloodstream. Overall, the jejunum plays a critical role in the digestion and absorption of nutrients from food.

Hyperoxaluria is a medical condition characterized by an excessive excretion of oxalate in the urine. Oxalate is a naturally occurring substance found in some foods and can also be produced by the body. When oxalate combines with calcium in the urine, it can form kidney stones or calcium oxalate deposits in the kidneys and other tissues, leading to kidney damage or systemic oxalosis. There are three types of hyperoxaluria: primary, secondary, and enteric. Primary hyperoxaluria is caused by genetic defects that affect the body's ability to regulate oxalate production, while secondary hyperoxaluria results from increased dietary intake or absorption of oxalate, or from other medical conditions. Enteric hyperoxaluria occurs in individuals with malabsorption syndromes, such as inflammatory bowel disease or after gastric bypass surgery, where excessive amounts of oxalate are absorbed from the gut into the bloodstream and excreted in the urine.

In anatomical terms, the stomach is a muscular, J-shaped organ located in the upper left portion of the abdomen. It is part of the gastrointestinal tract and plays a crucial role in digestion. The stomach's primary functions include storing food, mixing it with digestive enzymes and hydrochloric acid to break down proteins, and slowly emptying the partially digested food into the small intestine for further absorption of nutrients.

The stomach is divided into several regions, including the cardia (the area nearest the esophagus), the fundus (the upper portion on the left side), the body (the main central part), and the pylorus (the narrowed region leading to the small intestine). The inner lining of the stomach, called the mucosa, is protected by a layer of mucus that prevents the digestive juices from damaging the stomach tissue itself.

In medical contexts, various conditions can affect the stomach, such as gastritis (inflammation of the stomach lining), peptic ulcers (sores in the stomach or duodenum), gastroesophageal reflux disease (GERD), and stomach cancer. Symptoms related to the stomach may include abdominal pain, bloating, nausea, vomiting, heartburn, and difficulty swallowing.

Incretins are hormones that are released from the gut in response to food intake, with two major types being glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). These hormones stimulate the pancreas to produce insulin, suppress the release of glucagon from the pancreas, slow down gastric emptying, and promote satiety. Incretins play a significant role in regulating blood sugar levels after meals, and medications that mimic or enhance incretin action are used in the treatment of type 2 diabetes.

Treatment outcome is a term used to describe the result or effect of medical treatment on a patient's health status. It can be measured in various ways, such as through symptoms improvement, disease remission, reduced disability, improved quality of life, or survival rates. The treatment outcome helps healthcare providers evaluate the effectiveness of a particular treatment plan and make informed decisions about future care. It is also used in clinical research to compare the efficacy of different treatments and improve patient care.

Body Mass Index (BMI) is a measure used to assess whether a person has a healthy weight for their height. It's calculated by dividing a person's weight in kilograms by the square of their height in meters. Here is the medical definition:

Body Mass Index (BMI) = weight(kg) / [height(m)]^2

According to the World Health Organization, BMI categories are defined as follows:

* Less than 18.5: Underweight
* 18.5-24.9: Normal or healthy weight
* 25.0-29.9: Overweight
* 30.0 and above: Obese

It is important to note that while BMI can be a useful tool for identifying weight issues in populations, it does have limitations when applied to individuals. For example, it may not accurately reflect body fat distribution or muscle mass, which can affect health risks associated with excess weight. Therefore, BMI should be used as one of several factors when evaluating an individual's health status and risk for chronic diseases.

Gastrostomy is a surgical procedure that creates an opening through the abdominal wall into the stomach. This opening, called a stoma or gastrostomy tract, allows for the passage of a tube (gastrostomy tube) that can be used to provide enteral nutrition and hydration directly into the stomach when a person is unable to consume food or fluids by mouth due to various medical conditions such as dysphagia, neurological disorders, or head and neck cancers.

Gastrostomy tubes come in different types and sizes, including percutaneous endoscopic gastrostomy (PEG) tubes, laparoscopic gastrostomy tubes, and open surgical gastrostomy tubes. The choice of the procedure depends on various factors such as the patient's medical condition, anatomy, and overall health status.

The primary purpose of a gastrostomy is to ensure adequate nutrition and hydration for individuals who have difficulty swallowing or are unable to consume enough food or fluids by mouth to meet their nutritional needs. It can also help prevent complications associated with prolonged fasting, such as malnutrition, dehydration, and weight loss.

Follow-up studies are a type of longitudinal research that involve repeated observations or measurements of the same variables over a period of time, in order to understand their long-term effects or outcomes. In medical context, follow-up studies are often used to evaluate the safety and efficacy of medical treatments, interventions, or procedures.

In a typical follow-up study, a group of individuals (called a cohort) who have received a particular treatment or intervention are identified and then followed over time through periodic assessments or data collection. The data collected may include information on clinical outcomes, adverse events, changes in symptoms or functional status, and other relevant measures.

The results of follow-up studies can provide important insights into the long-term benefits and risks of medical interventions, as well as help to identify factors that may influence treatment effectiveness or patient outcomes. However, it is important to note that follow-up studies can be subject to various biases and limitations, such as loss to follow-up, recall bias, and changes in clinical practice over time, which must be carefully considered when interpreting the results.

Postoperative care refers to the comprehensive medical treatment and nursing attention provided to a patient following a surgical procedure. The goal of postoperative care is to facilitate the patient's recovery, prevent complications, manage pain, ensure proper healing of the incision site, and maintain overall health and well-being until the patient can resume their normal activities.

This type of care includes monitoring vital signs, managing pain through medication or other techniques, ensuring adequate hydration and nutrition, helping the patient with breathing exercises to prevent lung complications, encouraging mobility to prevent blood clots, monitoring for signs of infection or other complications, administering prescribed medications, providing wound care, and educating the patient about postoperative care instructions.

The duration of postoperative care can vary depending on the type and complexity of the surgical procedure, as well as the individual patient's needs and overall health status. It may be provided in a hospital setting, an outpatient surgery center, or in the patient's home, depending on the level of care required.

Avitaminosis is a medical condition that results from a deficiency of vitamins in the body. It occurs when an individual fails to consume sufficient amounts of essential vitamins, either due to poor nutrition, malabsorption, or increased requirements. The symptoms and severity of avitaminosis depend on the specific vitamin that is lacking and can range from mild to life-threatening.

For example:

* Avitaminosis A (deficiency of vitamin A) may lead to night blindness, dry skin, and impaired immunity.
* Avitaminosis B1 (deficiency of thiamine) can cause beriberi, a condition characterized by muscle weakness, peripheral neuropathy, and heart failure.
* Avitaminosis C (deficiency of ascorbic acid) may result in scurvy, which is marked by fatigue, swollen gums, joint pain, and anemia.
* Avitaminosis D (deficiency of calciferol) can lead to rickets in children or osteomalacia in adults, both of which are characterized by weakened bones and skeletal deformities.

To prevent avitaminosis, it is essential to maintain a balanced diet that includes all the necessary vitamins and minerals. In some cases, supplementation may be required to meet daily requirements, especially in individuals with medical conditions that affect nutrient absorption or increased needs. Always consult a healthcare professional before starting any supplement regimen.

Gastric Inhibitory Polypeptide (GIP) is a 42-amino acid long peptide hormone that is released from the K cells in the duodenum and jejunum of the small intestine in response to food intake, particularly carbohydrates and fats. It is also known as glucose-dependent insulinotropic polypeptide.

GIP has several physiological effects on the body, including:

* Incretin effect: GIP stimulates the release of insulin from the pancreas in a glucose-dependent manner, which means that it only increases insulin secretion when blood glucose levels are high. This is known as the incretin effect and helps to regulate postprandial glucose levels.
* Inhibition of gastric acid secretion: GIP inhibits the release of gastric acid from the stomach, which helps to protect the intestinal mucosa from damage caused by excessive acid production.
* Increase in blood flow: GIP increases blood flow to the intestines, which helps to facilitate nutrient absorption.
* Energy storage: GIP promotes the storage of energy by increasing fat synthesis and reducing fat breakdown in adipose tissue.

Overall, GIP plays an important role in regulating glucose metabolism, energy balance, and gastrointestinal function.

Food preferences are personal likes or dislikes towards certain types of food or drinks, which can be influenced by various factors such as cultural background, individual experiences, taste, texture, smell, appearance, and psychological factors. Food preferences can also be shaped by dietary habits, nutritional needs, health conditions, and medication requirements. They play a significant role in shaping an individual's dietary choices and overall eating behavior, which can have implications for their nutritional status, growth, development, and long-term health outcomes.

Coronary artery bypass, off-pump refers to a surgical procedure used to treat coronary artery disease (CAD), which is the narrowing or blockage of the coronary arteries due to the buildup of fatty deposits called plaques. This procedure is also known as off-pump coronary artery bypass (OPCAB) or beating heart bypass surgery.

In a coronary artery bypass, off-pump procedure, the surgeon creates a new pathway for blood to flow around the blocked or narrowed portion of the coronary artery using a healthy blood vessel from another part of the body, such as the chest wall (internal mammary artery) or the leg (saphenous vein). This allows oxygen-rich blood to bypass the blockage and reach the heart muscle directly.

The key difference between on-pump and off-pump coronary artery bypass surgery is that in an off-pump procedure, the heart continues to beat during the operation, and no heart-lung machine (cardiopulmonary bypass) is used. This approach has several potential advantages over on-pump CABG, including reduced risks of bleeding, stroke, and kidney failure. However, it may not be suitable for all patients, particularly those with complex or extensive coronary artery disease.

Overall, coronary artery bypass, off-pump surgery is a safe and effective treatment option for many patients with CAD, and can help improve symptoms, quality of life, and long-term outcomes.

Diabetes Mellitus, Type 2 is a metabolic disorder characterized by high blood glucose (or sugar) levels resulting from the body's inability to produce sufficient amounts of insulin or effectively use the insulin it produces. This form of diabetes usually develops gradually over several years and is often associated with older age, obesity, physical inactivity, family history of diabetes, and certain ethnicities.

In Type 2 diabetes, the body's cells become resistant to insulin, meaning they don't respond properly to the hormone. As a result, the pancreas produces more insulin to help glucose enter the cells. Over time, the pancreas can't keep up with the increased demand, leading to high blood glucose levels and diabetes.

Type 2 diabetes is managed through lifestyle modifications such as weight loss, regular exercise, and a healthy diet. Medications, including insulin therapy, may also be necessary to control blood glucose levels and prevent long-term complications associated with the disease, such as heart disease, nerve damage, kidney damage, and vision loss.

Prospective studies, also known as longitudinal studies, are a type of cohort study in which data is collected forward in time, following a group of individuals who share a common characteristic or exposure over a period of time. The researchers clearly define the study population and exposure of interest at the beginning of the study and follow up with the participants to determine the outcomes that develop over time. This type of study design allows for the investigation of causal relationships between exposures and outcomes, as well as the identification of risk factors and the estimation of disease incidence rates. Prospective studies are particularly useful in epidemiology and medical research when studying diseases with long latency periods or rare outcomes.

Appetite regulation refers to the physiological and psychological processes that control and influence the desire to eat food. This complex system involves a variety of hormones, neurotransmitters, and neural pathways that work together to help maintain energy balance and regulate body weight. The hypothalamus in the brain plays a key role in appetite regulation by integrating signals from the digestive system, fat cells, and other organs to adjust feelings of hunger and fullness.

The hormones leptin and ghrelin are also important regulators of appetite. Leptin is released from fat cells and acts on the hypothalamus to suppress appetite and promote weight loss, while ghrelin is produced in the stomach and stimulates appetite and promotes weight gain. Other factors that can influence appetite regulation include stress, emotions, sleep patterns, and cultural influences.

Abnormalities in appetite regulation can contribute to the development of eating disorders such as anorexia nervosa, bulimia nervosa, and binge eating disorder, as well as obesity and other health problems. Understanding the mechanisms of appetite regulation is an important area of research for developing effective treatments for these conditions.

A hernia is a protrusion of an organ or tissue through a weakened area in the abdominal wall, often appearing as a bulge beneath the skin. This condition can occur in various parts of the body such as the groin (inguinal hernia), navel (umbilical hernia), or site of a previous surgical incision (incisional hernia). Hernias may cause discomfort or pain, especially when straining, lifting heavy objects, or during bowel movements. In some cases, they may lead to serious complications like intestinal obstruction or strangulation, requiring immediate medical attention.

A reoperation is a surgical procedure that is performed again on a patient who has already undergone a previous operation for the same or related condition. Reoperations may be required due to various reasons, such as inadequate initial treatment, disease recurrence, infection, or complications from the first surgery. The nature and complexity of a reoperation can vary widely depending on the specific circumstances, but it often carries higher risks and potential complications compared to the original operation.

The postprandial period is the time frame following a meal, during which the body is engaged in the process of digestion, absorption, and assimilation of nutrients. In a medical context, this term generally refers to the few hours after eating when the body is responding to the ingested food, particularly in terms of changes in metabolism and insulin levels.

The postprandial period can be of specific interest in the study and management of conditions such as diabetes, where understanding how the body handles glucose during this time can inform treatment decisions and strategies for maintaining healthy blood sugar levels.

Surgical stapling is a medical technique that uses specialized staplers to place linear staple lines to close surgical incisions, connect or remove organs and tissues during surgical procedures. Surgical staples are made of titanium or stainless steel and can be absorbable or non-absorbable. They provide secure, fast, and accurate wound closure, reducing the risk of infection and promoting faster healing compared to traditional suturing methods.

The surgical stapler consists of a handle, an anvil, and a cartridge containing multiple staples. The device is loaded with staple cartridges and used to approximate tissue edges before deploying the staples. Once the staples are placed, the stapler is removed, leaving the staple line in place.

Surgical stapling has various applications, including gastrointestinal anastomosis, lung resection, vascular anastomosis, and skin closure. It is widely used in different types of surgeries, such as open, laparoscopic, and robotic-assisted procedures. The use of surgical stapling requires proper training and expertise to ensure optimal patient outcomes.

The omentum, in anatomical terms, refers to a large apron-like fold of abdominal fatty tissue that hangs down from the stomach and loops over the intestines. It is divided into two portions: the greater omentum, which is larger and hangs down further, and the lesser omentum, which is smaller and connects the stomach to the liver.

The omentum has several functions in the body, including providing protection and cushioning for the abdominal organs, assisting with the immune response by containing a large number of immune cells, and helping to repair damaged tissues. It can also serve as a source of nutrients and energy for the body during times of starvation or other stressors.

In medical contexts, the omentum may be surgically mobilized and used to wrap around injured or inflamed tissues in order to promote healing and reduce the risk of infection. This technique is known as an "omentopexy" or "omentoplasty."

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

Jejunal diseases refer to a range of medical conditions that affect the jejunum, which is the middle section of the small intestine. These diseases can cause various symptoms such as abdominal pain, diarrhea, bloating, nausea, vomiting, and weight loss. Some examples of jejunal diseases include:

1. Jejunal inflammation or infection (jejunitis)
2. Crohn's disease, which can affect any part of the gastrointestinal tract including the jejunum
3. Intestinal lymphoma, a type of cancer that can develop in the small intestine
4. Celiac disease, an autoimmune disorder that causes damage to the small intestine when gluten is consumed
5. Intestinal bacterial overgrowth (SIBO), which can occur due to various reasons including structural abnormalities or motility disorders of the jejunum
6. Meckel's diverticulum, a congenital condition where a small pouch protrudes from the wall of the intestine, usually located in the ileum but can also affect the jejunum
7. Intestinal strictures or obstructions caused by scarring, adhesions, or tumors
8. Radiation enteritis, damage to the small intestine caused by radiation therapy for cancer treatment.

The diagnosis and management of jejunal diseases depend on the specific condition and its severity. Treatment options may include medications, dietary modifications, surgery, or a combination of these approaches.

The preoperative period is the time period before a surgical procedure during which various preparations are made to ensure the best possible outcome for the surgery. This includes evaluating the patient's overall health status, identifying and managing any underlying medical conditions that could increase the risk of complications, obtaining informed consent from the patient, and providing preoperative instructions regarding medications, food and drink intake, and other aspects of preparation for the surgery.

The specific activities that occur during the preoperative period may vary depending on the type and complexity of the surgical procedure, as well as the individual needs and medical history of the patient. However, some common elements of the preoperative period include:

* A thorough medical history and physical examination to assess the patient's overall health status and identify any potential risk factors for complications
* Diagnostic tests such as blood tests, imaging studies, or electrocardiograms (ECGs) to provide additional information about the patient's health status
* Consultation with anesthesia providers to determine the appropriate type and dosage of anesthesia for the procedure
* Preoperative teaching to help the patient understand what to expect before, during, and after the surgery
* Management of any underlying medical conditions such as diabetes, heart disease, or lung disease to reduce the risk of complications
* Administration of medications such as antibiotics or anti-coagulants to prevent infection or bleeding
* Fasting instructions to ensure that the stomach is empty during the surgery and reduce the risk of aspiration (inhalation of stomach contents into the lungs)

Overall, the preoperative period is a critical time for ensuring the safety and success of surgical procedures. By taking a thorough and systematic approach to preparing patients for surgery, healthcare providers can help to minimize the risks of complications and ensure the best possible outcomes for their patients.

Blood glucose, also known as blood sugar, is the concentration of glucose in the blood. Glucose is a simple sugar that serves as the main source of energy for the body's cells. It is carried to each cell through the bloodstream and is absorbed into the cells with the help of insulin, a hormone produced by the pancreas.

The normal range for blood glucose levels in humans is typically between 70 and 130 milligrams per deciliter (mg/dL) when fasting, and less than 180 mg/dL after meals. Levels that are consistently higher than this may indicate diabetes or other metabolic disorders.

Blood glucose levels can be measured through a variety of methods, including fingerstick blood tests, continuous glucose monitoring systems, and laboratory tests. Regular monitoring of blood glucose levels is important for people with diabetes to help manage their condition and prevent complications.

Surgical anastomosis is a medical procedure that involves the connection of two tubular structures, such as blood vessels or intestines, to create a continuous passage. This technique is commonly used in various types of surgeries, including vascular, gastrointestinal, and orthopedic procedures.

During a surgical anastomosis, the ends of the two tubular structures are carefully prepared by removing any damaged or diseased tissue. The ends are then aligned and joined together using sutures, staples, or other devices. The connection must be secure and leak-free to ensure proper function and healing.

The success of a surgical anastomosis depends on several factors, including the patient's overall health, the location and condition of the structures being joined, and the skill and experience of the surgeon. Complications such as infection, bleeding, or leakage can occur, which may require additional medical intervention or surgery.

Proper postoperative care is also essential to ensure the success of a surgical anastomosis. This may include monitoring for signs of complications, administering medications to prevent infection and promote healing, and providing adequate nutrition and hydration.

Pathological constriction refers to an abnormal narrowing or tightening of a body passage or organ, which can interfere with the normal flow of blood, air, or other substances through the area. This constriction can occur due to various reasons such as inflammation, scarring, or abnormal growths, and can affect different parts of the body, including blood vessels, airways, intestines, and ureters. Pathological constriction can lead to a range of symptoms and complications depending on its location and severity, and may require medical intervention to correct.

Ghrelin is a hormone primarily produced and released by the stomach with some production in the small intestine, pancreas, and brain. It is often referred to as the "hunger hormone" because it stimulates appetite, promotes food intake, and contributes to the regulation of energy balance.

Ghrelin levels increase before meals and decrease after eating. In addition to its role in regulating appetite and meal initiation, ghrelin also has other functions, such as modulating glucose metabolism, insulin secretion, gastric motility, and cardiovascular function. Its receptor, the growth hormone secretagogue receptor (GHS-R), is found in various tissues throughout the body, indicating its wide range of physiological roles.

Malabsorption syndromes refer to a group of disorders in which the small intestine is unable to properly absorb nutrients from food, leading to various gastrointestinal and systemic symptoms. This can result from a variety of underlying conditions, including:

1. Mucosal damage: Conditions such as celiac disease, inflammatory bowel disease (IBD), or bacterial overgrowth that cause damage to the lining of the small intestine, impairing nutrient absorption.
2. Pancreatic insufficiency: A lack of digestive enzymes produced by the pancreas can lead to poor breakdown and absorption of fats, proteins, and carbohydrates. Examples include chronic pancreatitis or cystic fibrosis.
3. Bile acid deficiency: Insufficient bile acids, which are necessary for fat emulsification and absorption, can result in steatorrhea (fatty stools) and malabsorption. This may occur due to liver dysfunction, gallbladder removal, or ileal resection.
4. Motility disorders: Abnormalities in small intestine motility can affect nutrient absorption, as seen in conditions like gastroparesis, intestinal pseudo-obstruction, or scleroderma.
5. Structural abnormalities: Congenital or acquired structural defects of the small intestine, such as short bowel syndrome, may lead to malabsorption.
6. Infections: Certain bacterial, viral, or parasitic infections can cause transient malabsorption by damaging the intestinal mucosa or altering gut flora.

Symptoms of malabsorption syndromes may include diarrhea, steatorrhea, bloating, abdominal cramps, weight loss, and nutrient deficiencies. Diagnosis typically involves a combination of clinical evaluation, laboratory tests, radiologic imaging, and sometimes endoscopic procedures to identify the underlying cause. Treatment is focused on addressing the specific etiology and providing supportive care to manage symptoms and prevent complications.

Nesidioblastosis is a very rare condition that affects the pancreas, a gland located behind the stomach that produces hormones and enzymes to help with digestion. In nesidioblastosis, there is an abnormal increase in the number of cells called beta cells in the pancreas that produce insulin, a hormone that regulates blood sugar levels. This can lead to persistent hyperinsulinemia (high levels of insulin in the blood) and hypoglycemia (low blood sugar levels), even when the person has not eaten for several hours.

The term "nesidioblastosis" comes from the Greek words "nesis," meaning island, and "blastos," meaning germ or bud. It refers to the abnormal formation of islets of Langerhans, which are clusters of hormone-producing cells in the pancreas. In nesidioblastosis, there is an overgrowth of beta cells within these islets, leading to excessive insulin production and secretion.

Nesidioblastosis can be congenital (present at birth) or acquired later in life. It is often diagnosed in infants and young children but can also occur in adults. The symptoms of nesidioblastosis include sweating, tremors, irritability, seizures, and loss of consciousness due to low blood sugar levels. Treatment typically involves medication to control insulin secretion, dietary modifications, and, in some cases, surgery to remove part or all of the pancreas.

An anastomotic leak is a medical condition that occurs after a surgical procedure where two hollow organs or vessels are connected (anastomosed). It refers to the failure of the connection, resulting in a communication between the inside of the connected structures and the outside, which can lead to the escape of fluids, such as digestive contents or blood, into the surrounding tissues.

Anastomotic leaks can occur in various parts of the body where anastomoses are performed, including the gastrointestinal tract, vasculature, and respiratory system. The leakage can cause localized or systemic infection, inflammation, sepsis, organ failure, or even death if not promptly diagnosed and treated.

The risk of anastomotic leaks depends on several factors, such as the patient's overall health, the type and location of the surgery, the quality of the surgical technique, and the presence of any underlying medical conditions that may affect wound healing. Treatment options for anastomotic leaks vary depending on the severity and location of the leak, ranging from conservative management with antibiotics and bowel rest to surgical intervention, such as drainage, revision of the anastomosis, or resection of the affected segment.

I believe you are asking for a medical explanation or definition of "candy," which is not a term typically used in the medical field. However, I can provide some context regarding how it may be discussed in a medical setting.

Candy, also known as sweets or confectionery, generally refers to sugary snacks and treats. In a medical context, excessive consumption of candy can contribute to dental caries (cavities), obesity, type 2 diabetes, and other health issues related to poor nutrition and high sugar intake.

Healthcare professionals may advise patients, particularly children, to limit their candy consumption due to these potential health risks. Additionally, candies that contain ingredients like nuts or allergens can pose a risk for individuals with specific food allergies.

Nephrolithiasis is a medical term that refers to the presence of stones or calculi in the kidney. These stones can form anywhere in the urinary tract, including the kidneys, ureters, bladder, and urethra. Nephrolithiasis is also commonly known as kidney stones.

Kidney stones are hard deposits made up of minerals and salts that crystallize in the urine. They can vary in size from tiny sand-like particles to larger pebble or even golf ball-sized masses. Kidney stones can cause pain, bleeding, and infection if they block the flow of urine through the urinary tract.

The formation of kidney stones is often associated with a variety of factors such as dehydration, high levels of calcium, oxalate, or uric acid in the urine, family history, obesity, and certain medical conditions like gout or inflammatory bowel disease. Treatment for nephrolithiasis depends on the size and location of the stone, as well as the severity of symptoms. Small stones may pass spontaneously with increased fluid intake, while larger stones may require medication, shock wave lithotripsy, or surgical removal.

Satiety response is a term used in the field of nutrition and physiology to describe the feeling of fullness or satisfaction that follows food consumption. It is a complex process regulated by several factors, including the mechanical and chemical signals generated during digestion, hormonal responses, and psychological factors. The satiety response helps control food intake and energy balance by inhibiting further eating until the body has had enough time to metabolize and absorb the nutrients from the meal.

The satiety response can be influenced by various factors such as the type, volume, and texture of food consumed, as well as individual differences in appetite regulation and metabolism. Understanding the mechanisms underlying the satiety response is important for developing strategies to promote healthy eating behaviors and prevent overeating, which can contribute to obesity and other health problems.

A jejunoileal bypass is a surgical procedure that was once used to treat morbid obesity, but it is now rarely performed due to the high risk of serious complications. This procedure involves dividing the small intestine into two parts: the proximal jejunum and the distal ileum. The proximal jejunum is then connected to the colon, bypassing a significant portion of the small intestine where nutrient absorption occurs.

The goal of this surgery was to reduce the amount of food and nutrients that could be absorbed, leading to weight loss. However, it was found that patients who underwent jejunoileal bypass were at risk for developing severe malnutrition, vitamin deficiencies, bone disease, kidney stones, and liver problems. Additionally, many patients experienced unpleasant side effects such as diarrhea, bloating, and foul-smelling stools. Due to these significant risks and limited benefits, jejunoileal bypass has largely been replaced by other weight loss surgeries such as gastric bypass and sleeve gastrectomy.

Gastrointestinal (GI) hormones are a group of hormones that are secreted by cells in the gastrointestinal tract in response to food intake and digestion. They play crucial roles in regulating various physiological processes, including appetite regulation, gastric acid secretion, motility of the gastrointestinal tract, insulin secretion, and pancreatic enzyme release.

Examples of GI hormones include:

* Gastrin: Secreted by G cells in the stomach, gastrin stimulates the release of hydrochloric acid from parietal cells in the stomach lining.
* Ghrelin: Produced by the stomach, ghrelin is often referred to as the "hunger hormone" because it stimulates appetite and food intake.
* Cholecystokinin (CCK): Secreted by I cells in the small intestine, CCK promotes digestion by stimulating the release of pancreatic enzymes and bile from the liver. It also inhibits gastric emptying and reduces appetite.
* Gastric inhibitory peptide (GIP): Produced by K cells in the small intestine, GIP promotes insulin secretion and inhibits glucagon release.
* Secretin: Released by S cells in the small intestine, secretin stimulates the pancreas to produce bicarbonate-rich fluid that neutralizes stomach acid in the duodenum.
* Motilin: Secreted by MO cells in the small intestine, motilin promotes gastrointestinal motility and regulates the migrating motor complex (MMC), which is responsible for cleaning out the small intestine between meals.

These hormones work together to regulate digestion and maintain homeostasis in the body. Dysregulation of GI hormones can contribute to various gastrointestinal disorders, such as gastroparesis, irritable bowel syndrome (IBS), and diabetes.

A Gastrectomy is a surgical procedure involving the removal of all or part of the stomach. This procedure can be total (complete resection of the stomach), partial (removal of a portion of the stomach), or sleeve (removal of a portion of the stomach to create a narrow sleeve-shaped pouch).

Gastrectomies are typically performed to treat conditions such as gastric cancer, benign tumors, severe peptic ulcers, and in some cases, for weight loss in individuals with morbid obesity. The type of gastrectomy performed depends on the patient's medical condition and the extent of the disease.

Following a gastrectomy, patients may require adjustments to their diet and lifestyle, as well as potential supplementation of vitamins and minerals that would normally be absorbed in the stomach. In some cases, further reconstructive surgery might be necessary to reestablish gastrointestinal continuity.

An abdominal hernia refers to the protrusion of an organ or tissue through a weakened area in the abdominal wall, resulting in a bulge. This condition can occur due to various factors such as congenital defects, aging, obesity, pregnancy, persistent coughing, or previous surgeries that have left behind weak spots in the abdominal wall.

There are several types of abdominal hernias, including:

1. Inguinal Hernia: This is the most common type of hernia, occurring when the intestine or bladder protrudes through the inguinal canal in the lower abdomen. Inguinal hernias are more prevalent in men than women.
2. Femoral Hernia: This type of hernia occurs when the intestine or fatty tissue pushes through a weakened area near the femoral artery, located in the upper thigh region. Femoral hernias are more common in women, especially those who are pregnant or obese.
3. Incisional Hernia: This type of hernia develops at the site of a previous abdominal surgery where the abdominal muscles have weakened or failed to heal properly.
4. Umbilical Hernia: An umbilical hernia occurs when the intestine protrudes through the abdominal wall near the navel, often visible as a bulge around the belly button. This type of hernia is more common in infants but can also affect adults, particularly those who are overweight or have had multiple pregnancies.
5. Epigastric Hernia: An epigastric hernia occurs when fatty tissue protrudes through a weakened area between the breastbone and the navel. These hernias are usually small and often painless but can cause discomfort or complications if they become incarcerated or strangulated.

Abdominal hernias can vary in size, from small and barely noticeable to large and severely painful. Symptoms may include a visible bulge, localized pain or discomfort, especially when lifting heavy objects, coughing, or straining during bowel movements. In some cases, hernias may become incarcerated (trapped) or strangulated (blood supply is cut off), which can lead to severe pain, nausea, vomiting, and require immediate medical attention.

Treatment for abdominal hernias typically involves surgical repair, either through open surgery or laparoscopic techniques. The choice of procedure depends on various factors, including the size and location of the hernia, the patient's overall health, and their personal preferences. In some cases, watchful waiting may be recommended for small, asymptomatic hernias, but it is essential to consult with a healthcare professional to determine the best course of action.

Retrospective studies, also known as retrospective research or looking back studies, are a type of observational study that examines data from the past to draw conclusions about possible causal relationships between risk factors and outcomes. In these studies, researchers analyze existing records, medical charts, or previously collected data to test a hypothesis or answer a specific research question.

Retrospective studies can be useful for generating hypotheses and identifying trends, but they have limitations compared to prospective studies, which follow participants forward in time from exposure to outcome. Retrospective studies are subject to biases such as recall bias, selection bias, and information bias, which can affect the validity of the results. Therefore, retrospective studies should be interpreted with caution and used primarily to generate hypotheses for further testing in prospective studies.

Caloric restriction refers to a dietary regimen that involves reducing the total calorie intake while still maintaining adequate nutrition and micronutrient intake. This is often achieved by limiting the consumption of high-calorie, nutrient-poor foods and increasing the intake of nutrient-dense, low-calorie foods such as fruits, vegetables, and lean proteins.

Caloric restriction has been shown to have numerous health benefits, including increased lifespan, improved insulin sensitivity, reduced inflammation, and decreased risk of chronic diseases such as cancer, diabetes, and heart disease. It is important to note that caloric restriction should not be confused with starvation or malnutrition, which can have negative effects on health. Instead, it involves a careful balance of reducing calorie intake while still ensuring adequate nutrition and energy needs are met.

It is recommended that individuals who are considering caloric restriction consult with a healthcare professional or registered dietitian to ensure that they are following a safe and effective plan that meets their individual nutritional needs.

Gastroenterostomy is a surgical procedure that creates an anastomosis (a connection or junction) between the stomach and the small intestine, usually between the stomach's lesser curvature and the jejunum (the second part of the small intestine). This procedure is often performed to bypass a diseased or obstructed portion of the gastrointestinal tract, such as in the case of gastric ulcers, tumors, or other conditions that prevent normal digestion and absorption.

There are different types of gastroenterostomy procedures, including:
1. Billroth I (or "gastroduodenostomy"): The stomach is connected directly to the duodenum (the first part of the small intestine).
2. Billroth II (or "gastrojejunostomy"): The stomach is connected to the jejunum, bypassing the duodenum.
3. Roux-en-Y gastrojejunostomy: A more complex procedure in which a portion of the jejunum is separated and reconnected further down the small intestine, creating a Y-shaped configuration. This type of gastroenterostomy is often used in bariatric surgery for weight loss.

The choice of gastroenterostomy technique depends on the specific medical condition being treated and the patient's overall health status.

Vascular patency is a term used in medicine to describe the state of a blood vessel (such as an artery or vein) being open, unobstructed, and allowing for the normal flow of blood. It is an important concept in the treatment and management of various cardiovascular conditions, such as peripheral artery disease, coronary artery disease, and deep vein thrombosis.

Maintaining vascular patency can help prevent serious complications like tissue damage, organ dysfunction, or even death. This may involve medical interventions such as administering blood-thinning medications to prevent clots, performing procedures to remove blockages, or using devices like stents to keep vessels open. Regular monitoring of vascular patency is also crucial for evaluating the effectiveness of treatments and adjusting care plans accordingly.

Calcium citrate is a dietary supplement and medication that contains calcium in the form of calcium citrate malate. It is used to prevent and treat calcium deficiency, and as a dietary supplement for people who do not get enough calcium from their diets. Calcium citrate is also used to treat conditions caused by low levels of calcium in the blood, such as osteoporosis and certain types of muscle cramps. It works by increasing the amount of calcium in the body, which is necessary for many important functions, including bone formation and maintenance, muscle contraction, and nerve function. Calcium citrate is available in tablet and powder form, and it can be taken with or without food.

The saphenous vein is a term used in anatomical description to refer to the great or small saphenous veins, which are superficial veins located in the lower extremities of the human body.

The great saphenous vein (GSV) is the longest vein in the body and originates from the medial aspect of the foot, ascending along the medial side of the leg and thigh, and drains into the femoral vein at the saphenofemoral junction, located in the upper third of the thigh.

The small saphenous vein (SSV) is a shorter vein that originates from the lateral aspect of the foot, ascends along the posterior calf, and drains into the popliteal vein at the saphenopopliteal junction, located in the popliteal fossa.

These veins are often used as conduits for coronary artery bypass grafting (CABG) surgery due to their consistent anatomy and length.

I'm sorry for any confusion, but "pleasure" is not typically defined in medical terms. It is more commonly understood in psychological or philosophical contexts. Pleasure is often described as a positive emotional response associated with satisfying needs and desires, or enjoying certain experiences. However, in a medical context, the term might be used to describe the positive feelings some people may associate with certain health-related behaviors or experiences. For example, a person might derive pleasure from engaging in regular exercise, which can have positive effects on their physical and mental health.

Body weight is the measure of the force exerted on a scale or balance by an object's mass, most commonly expressed in units such as pounds (lb) or kilograms (kg). In the context of medical definitions, body weight typically refers to an individual's total weight, which includes their skeletal muscle, fat, organs, and bodily fluids.

Healthcare professionals often use body weight as a basic indicator of overall health status, as it can provide insights into various aspects of a person's health, such as nutritional status, metabolic function, and risk factors for certain diseases. For example, being significantly underweight or overweight can increase the risk of developing conditions like malnutrition, diabetes, heart disease, and certain types of cancer.

It is important to note that body weight alone may not provide a complete picture of an individual's health, as it does not account for factors such as muscle mass, bone density, or body composition. Therefore, healthcare professionals often use additional measures, such as body mass index (BMI), waist circumference, and blood tests, to assess overall health status more comprehensively.

"Length of Stay" (LOS) is a term commonly used in healthcare to refer to the amount of time a patient spends receiving care in a hospital, clinic, or other healthcare facility. It is typically measured in hours, days, or weeks and can be used as a metric for various purposes such as resource planning, quality assessment, and reimbursement. The length of stay can vary depending on the type of illness or injury, the severity of the condition, the patient's response to treatment, and other factors. It is an important consideration in healthcare management and can have significant implications for both patients and providers.

I'm sorry for any confusion, but "Utah" is not a medical term or concept. It is a geographical location, being the 45th state admitted to the United States of America. If you have any questions related to medical topics, I would be happy to try and help answer those for you!

Dumping syndrome, also known as rapid gastric emptying, is a condition that typically occurs in people who have had surgery to remove all or part of their stomach (gastrectomy) or have had a procedure called a gastrojejunostomy. These surgeries can lead to the stomach's contents entering the small intestine too quickly, causing symptoms such as nausea, vomiting, abdominal cramping, diarrhea, dizziness, and sweating.

There are two types of dumping syndrome: early and late. Early dumping syndrome occurs within 30 minutes after eating, while late dumping syndrome occurs 1-3 hours after eating. Symptoms of early dumping syndrome may include nausea, vomiting, abdominal cramping, diarrhea, bloating, dizziness, and fatigue. Late dumping syndrome symptoms may include hypoglycemia (low blood sugar), which can cause sweating, weakness, confusion, and rapid heartbeat.

Treatment for dumping syndrome typically involves dietary modifications, such as eating smaller, more frequent meals that are low in simple sugars, and avoiding fluids during meals. In some cases, medication may be prescribed to help slow down gastric emptying or manage symptoms. If these treatments are not effective, surgery may be necessary to correct the problem.

Leakage of an anastomosis can occur in about 2% of Roux-en-Y gastric bypass and less than 1% in mini gastric bypass. Leaks ... in Poland gastric bypass costs around £4,000, whereas in Turkey it costs £3,200. Gastric bypass surgery has an emotional and ... while the pouch of the gastric bypass may be 15 mL in size. The gastric bypass pouch is usually formed from the part of the ... Gastric bypass surgery refers to a technique in which the stomach is divided into a small upper pouch and a much larger lower " ...
The attempt to reverse the bypass to normal anatomy can cause rare but serious complications. The parts of the stomach and ... Gastric bypass or Roux-en-Y gastric bypass operations are reversible, but the reversal procedure is risky. ... Can You Live a Normal Life After Gastric Bypass?. Gastric bypass surgery, also known as a Roux-en-Y, is one kind of weight-loss ... Gastric bypass or Roux-en-Y gastric bypass operations are reversible, but the reversal procedure is risky. The attempt to ...
Gastric bypass is surgery that helps you lose weight by changing how your stomach and small intestine handle the food you eat. ... Gastric bypass is surgery that helps you lose weight by changing how your stomach and small intestine handle the food you eat. ... Bariatric surgery - gastric bypass; Roux-en-Y gastric bypass; Gastric bypass - Roux-en-Y; Weight-loss surgery - gastric bypass ... Gastric bypass can be done in two ways. With open surgery, your surgeon makes a large surgical cut to open your belly. The ...
Cooper-Clarke had gastric bypass surgery in March 2010, the Daily Mail reported. The procedure uses staples to shrink the ... Choking Death Linked to Gastric Bypass Surgery. A U.K. woman choked on food that wouldnt fit into her stomach, docs say. ... But experts say gastric bypass patients are no more likely to choke than someone who didnt undergo the surgery. ... The inquest concluded Cooper-Clarkes gastric bypass surgery was carried out properly, and that her behavior after the ...
We explain which parts of Medicare cover gastric bypass surgery, costs, eligibility, and more. ... Medicare covers gastric bypass if you meet certain criteria. ... Gastric bypass, medically known as Roux-en-Y gastric bypass, is ... There are two types of gastric bypass surgery: open gastric bypass and laparoscopic gastric bypass. Open gastric bypass surgery ... The entire gastric bypass procedure creates a "bypass" of the normal functions of the digestive system, which greatly decreases ...
Roux-en-Y gastric bypass led to improved health outcomes without costing a significant amount of money in patients with ... "Our study suggests that in most cases, gastric bypass is the preferred strategy when looking at a 5-year time frame, despite ... Cite this: Gastric Bypass Best Option for Severe Obesity With Diabetes? - Medscape - Feb 24, 2022. ... Overall, Roux-en-Y gastric bypass (RYGB) was preferred when compared to sleeve gastrectomy or medical therapy in patients with ...
Gastric Bypass Surgeons near me. By weighing reviews and other important factors, we can help you find the right care. ... Gastric Bypass Surgeons and how to choose the right one for you. Learn more about Bariatric / Gastric Bypass Surgeons. A ... Other professional titles include gastric bypass or gastric band surgeon if the surgeon specializes in a particular type of ... Bariatric surgeons perform weight loss surgery, such as gastric banding and gastric bypass, and manage long-term weight loss. A ...
Roux-en-Y gastric bypass at Massachusetts General Hospital is a weight loss surgery that reduces the size of the stomach. Read ... How is Roux-en-Y Gastric Bypass Performed?. During gastric bypass surgery, a surgeon creates a small gastric pouch from the top ... Roux-en-Y Gastric Bypass Surgery. Roux-en-Y gastric bypass (RYGB) is a weight loss surgery that reduces the size of the stomach ... About Roux-en-Y Gastric Bypass. RYGB is recommended for patients based on the following benefits: *Average loss of 45% to 85% ...
... no patient required ring removal or conversion to Roux-en-Y gastric bypass surgery. Food intolerance/vomiting was present in 1 ... so called laparoscopic banded one anastomosis gastric bypass (LBOAGB). ,i,Methods,/i,. 86 patients undergoing LBOAGB between ... publications suggest that dumping syndrome and weight regain might be reduced by placing a silicone ring over the gastric pouch ... i,Introduction,/i,. Laparoscopic one anastomosis gastric bypass (LOAGB) is a relatively new procedure for the treatment of ...
Gastric bypass surgery to help you lose weight when diet and exercise havent worked and your health is at risk because of ... Gastric bypass surgery: your procedure Your gastric bypass surgery takes one to three hours, but youll stay in hospital for ... Gastric bypass surgery: what to expect at Spire South Bank Hospital Located in the city of Worcester, we provide comprehensive ... During a gastric bypass, your surgeon will reduce the size of your stomach and connect it to the lower part of your small ...
Inclination towards sweet-tasting foods may be decreased with the help of gastric bypass surgery according to a study by ... "Roux-en-Y gastric bypass surgery is the most common effective treatment for morbid obesity," said Andras Hajnal, M.D., Ph.D., ... A small sized gastric pouch is created in this surgery which bypasses a part of the upper small intestine. This method results ... Gastric bypass may help in altering sweet taste perception. Nov 03, 2010 09:29 AM. By ...
... Eighty percent of your stomach filled all day with indigestible mystery fiber, for only $480.00? Sign ...
... one-anastomosis gastric bypass (OAGB) and Roux-en-Y Gastric Bypass (RYGB) in a preclinical rat model. We evaluated the ... On the contrary, BA concentrations were the highest in the residual gastric pouch of OAGB-15 rats. Yet, no association could be ... established between the esogastric lesions and malabsorption, weight loss, or gastric bile acid concentrations. In conclusion, ... Malabsorption and intestinal adaptation after one anastomosis gastric bypass compared with Roux-en-Y gastric bypass in rats. Am ...
... after gastric bypass surgery for the veteran population. ... counseling is important for veterans undergoing gastric bypass ... gastric bypass surgery. *A study showed that patients with no follow-up visits after gastric bypass surgery were 4.6 times more ... index after gastric bypass surgery. *Distinguish the role of nutrition counseling in patients undergoing gastric bypass surgery ... Roux-en-Y gastric bypass (RYGB) surgery has become the gold standard among bariatric surgeries, and it is the most commonly ...
Roux-en-Y Gastric Bypass Surgery in Situs Inversus Patient. Caolan Walsh, MD, FRCSC, MBA, Amer R Jarrar, MD, Gabriel Roy, MD, ... 61-Year-old Female presenting for Roux-en-Y Gastric Bypass Surgery, the patient has a complete mirror image of her intra- ...
The gastric bypass rats seemed to avoid saccharine, whereas the sham-operated rats did not. This implicated that the digestion ... The most efficient procedure is Roux-en-Y gastric bypass where the stomach is stapled to form a tiny bag-like elevation at ... The team has now planned to examine these genes to see if there were chances to replicate the results of gastric bypass without ... Now, as per a study from scientists at Imperial college London, gastric bypass surgery changes diet choices of persons in a way ...
Barretts Esophagus After Roux-en- Y Gastric Bypass: Does Regression Occur?. Maria Veronica Gorodner, MD, Gaston Clemente, MD, ... There is no question that laparoscopic Roux -en- Y gastric bypass (LRYGB) is the best treatment option for obesity combined ... Methods and Procedures: Candidates for bariatric surgery were studied with esophagogastroduodenoscopy (EGD) and gastric biopsy ...
Discusses gastric bypass surgery to treat obesity. Discusses why and when it is done. Covers laparoscopic and open Roux-en-Y ... Gastric Bypass Surgery. Surgery Overview. A gastric bypass (also called Roux-en-Y gastric bypass) is surgery to help you lose ... A gastric bypass (also called a Roux-en-Y gastric bypass) is suitable for people who are severely overweight and who have not ... Other risks from a gastric bypass (also called a Roux-en-Y gastric bypass) include: Dumping syndrome.. This causes nausea, ...
... on SlideServe. View and share presentations and documents online. ...
Learn about the ins and outs of gastric bypass coverage, including Medicare, here. ... Insurance Coverage for Gastric Bypass Surgery. Gastric bypass surgery can cost anything from $18,000 to $22,000. The good news ... for gastric bypass.. "Usual" refers to the normal rate charged for gastric bypass, and "customary" refers to the rates charged ... Does Medicare Cover Gastric Bypass?. Medicare, the U.S. government health plan for people 65 or older, will cover gastric ...
Gastric Bypass Surgery Istanbul can provide an effective solution when the diet has not given significant results. ... Affordable Gastric Bypass Surgery Istanbul - Get Free Quote Now!. A Helpful Guide for Gastric Bypass Surgery Istanbul. Gastric ... Gastric Bypass Centers Cost Comparison in Istanbul, Turkey. Provider. Procedure. Price. Erdem Hospital. Gastric Bypass, Obesity ... Gastric Bypass Cost Comparison in Turkey. Country. Procedure. Price. Canada. Gastric Bypass, Obesity/Bariatric Surgery. $20500 ...
LOSING weight can be hard but one slimmer found the motivation to remove herself from the gastric bypass list by losing a ... "I knew I had to do something and my GP put me down for the gastric bypass but one day, while I was eating a plate of spaghetti ... After Zena Gavey, 55, tipped the scales at 19st 5lb, she was put on the gastric bypass list by her GP in an effort to prolong ... LOSING weight can be hard but one slimmer found the motivation to remove herself from the gastric bypass list by losing a ...
No gastric bypass, no surgery required. Sounds magical, ... Allurion offers gastric bypass surgery in a pill. Sarah Buhr @ ... No gastric bypass, no surgery required. Sounds magical, but Boston-based Allurion has created the only non-invasive gastric ... Gastric balloons are nothing new, but you usually need anesthesia and a doctor to insert them. That makes the whole process ... Inserting a gastric balloon has the potential to damage the esophagus and risks infection from bacteria. Anesthesia and the ...
All foreign patients seeking the best yet low cost Gastric Bypass Surgery in India can go through the detailed overview on the ... Gastric Bypass Surgery in India. Gastric bypass (aka Roux-en-y gastric bypass surgery) is one of the most common and successful ... Cost of Gastric Bypass Surgery In India. The gastric bypass surgery cost in India will be around $6,000, whereas for those ... Who is Fit to Undergo a Gastric Bypass. Gastric bypass is recommended only when the patient is severely obese and failed to ...
Articles tagged with "gastric bypass surgery". Weight Loss Surgery May Reduce Risk of Developing Gout. Madeline Kennedy , ... Does Gastric Bypass Result in Reduced Absorption of Methotrexate?. Iris Zink, NP , March 1, 2015. ... Reuters Health)-Obese people who have weight loss surgeries, such as gastric bypass, are much less likely than those who dont ...
Gastric Banding and Bypass for Morbid Obesity - Preoperative Assessment, Operative Techniques and Postoperative Monitoring. ...
Can you have a second gastric bypass surgery? Check out right here and right now! Read this article and find out everything ... Can you have a second gastric bypass surgery?. Gastric bypass Roux-en-Y is also a common change procedure. People who have not ... Gastric bypass Roux-en-Y is the most common type of weight loss surgery in the US. During this operation, we use staples to ... In the gastric bypass, the stomach is divided into a small upper bag that processes food and a much larger lower part that is ...
Welcome to Barix Clinics, Americas leading bariatric weight loss surgery centers where we lead by combining cutting edge technologies with sincere patient care. | Barix Clinics
I am about to have a gastric by-pass and was googling the bypass diet when I saw what I thought was a response to an article on ... The gastric bypass gave me a second chance at life. I know what it feels like to be proud of myself, to love who I am. Why ... Thinking about gastric bypass surgery? Try following the diet for a couple of weeks and see if you like it:. *You can eat no ... I googled (gastric bypass daily diet) and came up with alot more of the diets actually written out. I am going to call a couple ...
Metabolic remission precedes possible weight regain after gastric bypass surgery. *Mark. Rogova, Oksana LU ; Herzog, Katharina ... OBJECTIVE: Some patients regain weight to a variable extent from 1 year after Roux-en-Y gastric bypass surgery (RYGB), though ... OBJECTIVE: Some patients regain weight to a variable extent from 1 year after Roux-en-Y gastric bypass surgery (RYGB), though ... Some patients regain weight to a variable extent from 1 year after Roux-en-Y gastric bypass surgery (RYGB), though rarely ...

No FAQ available that match "gastric bypass"

No images available that match "gastric bypass"